No Longer Accepting Lipitor Cases

Lipitor Causing Kidney Disease Lawsuits

In addition to other severe complications, Lipitor has recently been linked to kidney disease. In some cases, patients who took lipitor developed a rare form of muscle disease known as rhabdomyolysis.

This condition breaks down muscle tissue, creating dangerous substances that are able to enter the bloodstream. Once in the blood, these substances can cause significant damage to the kidneys. The U.S. Food and Drug Administration has recommended that physicians examine patients kidneys prior to prescribing them Lipitor, since in some cases this condition has proven to be fatal.

Lipitor Kidney Disease Lawsuits

Our dangerous drug attorneys can help if you or someone you care about suffered kidney disease from Lipitor.   Lawsuits have been filed against the drug maker by both patients and their families seeking compensation for injuries caused by this dangerous drug.  You may be entitled to a settlement.

Our No Fee Promise on Lipitor Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Lipitor Claim

Our Lipitor lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Lipitor lawsuit claims.

View Sources

Food and Drug Administration. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drug. Feb 28 2012.

Lipitor Side Effects, 

Panchangam V1. Statin-associated acute interstitial nephritis and rhabdomyolysis. Saudi J Kidney Dis Transpl. 2014 May;25(3):659-60.

Dormuth CR1, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P; Canadian Network for Observational Drug Effect Studies. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.

Marusic S1, Lisicic A, Horvatic I, Bacic-Vrca V, Bozina N. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. Int J Clin Pharm. 2012 Dec;34(6):825-7. doi: 10.1007/s11096-012-9717-0. Epub 2012 Oct 18.